Literature DB >> 7742554

Transcript analysis of D category phenotypes predicts hybrid Rh D-CE-D proteins associated with alteration of D epitopes.

C Rouillac1, Y Colin, N C Hughes-Jones, M Beolet, A M D'Ambrosio, J P Cartron, C Le Van Kim.   

Abstract

The RH blood group locus from RhD-positive donors is composed of two closely related genes, RHCE and RHD, encoding the Cc/Ee and D antigens, respectively. The major Rh antigen, D, is serologically defined as a mosaic of at least nine determinants (epD1 to epD9), and the lack of expression of some of these D epitopes at the surface of variant red blood cells defines the D category phenotypes. In this report, we have analyzed the Rh transcripts from reticulocytes of different D category phenotypes (DIVa, DIVb, DVa, and DFR). Although Southern blot analysis did not sow obvious deletions within the RHD gene, sequence analysis of the RhD transcripts indicated that, in all cases studied, the lack of D epitopes is associated with substitutions, in the deduced polypeptides, of amino acids specific of the RhD protein by those encoded at the equivalent position by the RHCE gene. These results strongly suggested that the D category phenotypes resulted from segmental DNA replacement between RHD-specific fragments and their equivalents in the RHCE gene. The regions involved in the DIVa, DIVb, DVa, and DFR phenotypes were shown to encompass all or part of the exons 3 and 7, exons 7 to 9, exon 5, and exon 4, respectively. All protein variants encoded by these rearranged RH genes represent new CE-D-CE hybrid molecules that retain only some of the nine D epitopes. Because segmental DNA replacements have been previously identified in other Rh variant genomes, we postulate that such genomic rearrangements between different regions of the RHCE and RHD genes should be one of the most frequent events involved in the extreme polymorphism of the RH blood group system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7742554

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  Molecular genetics and clinical applications for RH.

Authors:  Willy A Flegel
Journal:  Transfus Apher Sci       Date:  2011-01-28       Impact factor: 1.764

2.  A recombination hot spot in the Rh genes revealed by analysis of unrelated donors with the rare D-- phenotype.

Authors:  T J Kemp; M Poulter; B Carritt
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

3.  Genetic recombination at the human RH locus: a family study of the red-cell Evans phenotype reveals a transfer of exons 2-6 from the RHD to the RHCE gene.

Authors:  C H Huang; Y Chen; M Reid; S Ghosh
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

4.  RHCE*ceTI encodes partial c and partial e and is often in cis to RHD*DIVa.

Authors:  Connie M Westhoff; Sunitha Vege; Christine Halter Hipsky; Kim Hue-Roye; Tamara Copeland; Randall W Velliquette; Trina Horn; Christine Lomas-Francis; Marion E Reid
Journal:  Transfusion       Date:  2012-07-13       Impact factor: 3.157

5.  Characterization of the recombination hot spot involved in the genomic rearrangement leading to the hybrid D-CE-D gene in the D(VI) phenotype.

Authors:  G Matassi; B Chérif-Zahar; I Mouro; J P Cartron
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

6.  The RHD gene is highly detectable in RhD-negative Japanese donors.

Authors:  H Okuda; M Kawano; S Iwamoto; M Tanaka; T Seno; Y Okubo; E Kajii
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

Review 7.  Genotyping in Sickle Cell Disease Patients: The French Strategy.

Authors:  Aline Floch; Christophe Tournamille; Btissam Chami; France Pirenne
Journal:  Transfus Med Hemother       Date:  2018-07-06       Impact factor: 3.747

8.  Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women.

Authors:  Christelle Rouillac-Le Sciellour; Philippe Puillandre; Rolande Gillot; Céline Baulard; Sylvain Métral; Caroline Le Van Kim; Jean-Pierre Cartron; Yves Colin; Yves Brossard
Journal:  Mol Diagn       Date:  2004

9.  Whole exon 5 and intron 5 replaced by RHCE in DVa(Hus).

Authors:  Chaopeng Shao; Wen Xiong; Wei Wang
Journal:  J Hum Genet       Date:  2004-01-09       Impact factor: 3.172

10.  D category IV: a group of clinically relevant and phylogenetically diverse partial D.

Authors:  Inge von Zabern; Franz F Wagner; Joann M Moulds; John J Moulds; Willy A Flegel
Journal:  Transfusion       Date:  2013-03-05       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.